Category Archives: Bad Drugs
Light at the end of the tunnel…Finally
The makers of the blood-thinning drug Xarelto, Bayer and Johnson & Johnson, have agreed to settle the 25,000 consolidated cases against them for $775 million.
Makers of the powerful blood thinner #Xarelto have agreed to pay $775 million to settle about 25,000 #lawsuits that claim the drug caused serious injuries such as internal bleeding, stroke and death. Learn more here: https://t.co/sXgDasZypO
— Drugwatch (@Drug_watch) April 2, 2019
The massive mass tort settlement resolved the cases by creating a fund that the individual plaintiffs in each case can seek compensation from. Curiously, in six of the trials of individual cases, the drug makers actually won. However, facing mounting litigation costs for continuing to battle it out, the companies’ statement explains that settling was an economic decision. Despite the big settlement figure, the path actually pans out.
What Are These Cases About?
The Xarelto cases involve claims that the drug maker failed to warn those patients prescribed the drug of several, potentially fatal, side effects. Complicating matters is the fact that prescribed patients cannot simply stop taking the drug without risk.
For several years when the drug was first sold, those risks were not disclosed, which basically meant anyone taking the drug prior to the disclosure in 2015 potentially had/has a claim. The value of that claim however is likely to vary based on whether there has been an impact to the person’s life as a result of the failure to disclose.
— Living Safely HealthID (@LS_HelpID) April 2, 2019
Big Numbers, But Not Big Enough?
While that $775 million figure might sound impressive, even assuming no attorney fees or costs come out of that number, which is unlikely, each of the 25,000 cases would have $31,000 each (hypothetically if everyone got the same amount, which isn’t likely to be the case as many suffered more injury than others).
As Forbes explains, the drug makers are basically getting off easy here. Given the sheer number of cases that $775 million settles out, it’s clear the drug makers have gotten the benefit of the bargain in this settlement.
$2.2 Billion Risperdal Settlement
Johnson & Johnson has agreed to pay more than $2.2 billion in criminal and civil fines to settle accusations that it improperly promoted the antipsychotic drug Risperdal to older adults, children and people with developmental disabilities, the Justice …
How many children are prescribed this drug in Ireland and the UK still? J.&J. to Pay $2.2 Billion in Risperdal Settlement https://t.co/Oq0M6ppdQz
— Dr Maurice Fenton (@EmpowerIreland) March 6, 2019
Johnson & Johnson Settles 3rd Risperdal Lawsuit for $158M
They just got dinged with a $158 million settlement in a Medicaid fraud case in Texas for “making false or misleading statements about the safety, cost and effectiveness of the expensive anti-psychotic medication Risperdal, and improperly influencing
1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney I – WSIL-TV 3 Southern Illinois
Invokana lawsuits filed on behalf of individuals who developed life-threatening complications allegedly related to treatment with the Type 2 diabetes medication continue to mount in courts throughout the United States.
— Kristi P. Carter (@successthang) May 2, 2018
If you or a loved one has taken the diabetes drug Invokana and suffered a limb amputations contact The Webster Law Firm. The FDA has recently issued a warning regarding the study of the Invokana drug and it's link to limb amputations. #thewebsterlawfirm #houstonlawyer #invokanalawsuit #diabetes2 #makeithappen @jason.webster66
Johnson & Johnson: INVOKANA Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus (T2DM) with or at …
— Top Class Actions (@TopClassActions) May 2, 2018
Testosterone ruling could bring lawsuits
Athletics chiefs could face legal action after bringing in a rule that may end the competitive career of Caster Semenya, a leading sports scientist has warned.
The IAAF will today announce a new limit of 5 nanomoles of naturally produced testosterone per …
Yeah gel is synthetic, and hasto go through layers of skin tissue to be absorbed into blood stream. You seen this lawsuit on the gels? https://t.co/d7tSostNS5
— IRC not rootbeer (@iowa_is_my_name) May 5, 2018
AbbVie, facing thousands of lawsuits about its AndroGel testosterone supplement, notches a significant win
AbbVie’s AndroGel has been blamed for causing heart attacks in men who used the gel.
But a jury in Chicago decided in January the drugmaker did not cause a 72-year-old man’s heart attack. AbbVie faces thousands of lawsuits alleging AndroGel caused heart …
Risperdal Judge Explains Reasons for Denying Janssen a New Trial
A recent plaintiff verdict overturned, the Pennsylvania state judge assigned to the case explained last month why he denied a request by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. for a new trial in the Risperdal side effects …
— Experts.com (@Experts_Com) September 19, 2017
Philadelphia Risperdal Docket Almost Triples in First Half of 2017
The number of cases involving the anti-psychotic drug Risperdal almost tripled in the first half of 2017, jumping from approximately 2,000 cases at the beginning of the year to more than 5,500 as of June 2017, comprising the largest mass tort …
Risperdal Plaintiff Green Lighted to Pursue Risperdal Lawsuit in New York
New York, NY
The plaintiff in a Risperdal lawsuit who faced a petition for summary judgement on the part of the manufacturer, won the right to pursue the majority of his claims following a ruling by a New York judge that testimony by an expert witness …
Risperdal Lawsuit Filings Exceed 6000 in Pennsylvania Mass Tort, as Court Prepares for Sept Meeting
Plaintiffs who allegedly developed gynecomastia due to treatment with Risperdal continue to file claims in the Pennsylvania mass tort program currently underway in the Philadelphia Court of Common Pleas.
Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict
According to testimony given by Pledger’s mother during the trial in the family’s Risperdal lawsuit. Benita Pledger also testified that her son would habitually cover himself with a large towel when he stepped from the shower, before he could bring …
Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third
New Orleans, LA
The second bellwether Xarelto lawsuit in multidistrict litigation over allegations of Xarelto bleed-out in association with the new age blood thinner has gone, like the first, to the defendant.
While this may prove disappointing to …
— Top Class Actions (@TopClassActions) July 27, 2017
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Johnson & Johnson and Bayer are two-for-two in defending Xarelto against liability lawsuits.
The drugmakers aren’t in the clear yet, though, with another bellwether trial set for August and thousands of additional suits claim the blockbuster blood …
Bayer, Janssen Win 2nd Xarelto Bellwether Trial
A New Orleans federal jury on Monday awarded a defense verdict to Janssen and Bayer in the second bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood …
J&J, Bayer Cleared of Responsibility at Xarelto Trial
Johnson & Johnson and Bayer AG aren’t responsible for a Xarelto user’s internal bleeding, a jury found in the first trial over the blood-thinning drug.
J&J and Bayer didn’t mislead a Louisiana man and his doctors about the blood-thinning drug’s health …
Risperdal Lawsuit Hits 18,000 and Climbing
The Risperdal lawsuit count now stands at a number above 18,000.
To that end a staggering number of cases name pharmaceutical giants Johnson & Johnson (J&J) and subsidiary Janssen Pharmaceuticals as defendants.
Most allege …
— Top Class Actions (@TopClassActions) June 30, 2017
Parties to Pennsylvania Risperdal Gynecomastia Lawsuits Set to Meet Next Month to Discuss Status of Mass Tort
Thousands of Risperdal lawsuits involving the antipsychotic medication’s alleged potential to cause gynecomastia (male breast growth) continue to move forward in a mass tort litigation now underway in …
Johnson & Johnson’s Action Spikes Risperdal Cases Filed in PA Court
Risperdal lawsuits are highly sensitive because the plaintiffs involved here are psychologically compromised young boys.
Risperdal (risperidone) is an antipsychotic medication that is believed to have caused mental and physical trauma and torture to …
“Risperdal Boys” Photo Project Vividly Captures Pain of Gynecomastia
Thousands of Risperdal lawsuits have been filed in U.S. courts on behalf of men and boys who allegedly developed gynecomastia due to treatment with the antipsychotic drug.
Now a new photography project is vividly capturing the suffering endured by …
Seeking Help Is Difficult for Bipolar Man with Risperdal “Man Boobs”
Most of us don’t think twice to talk with our doctor if we think there is an issue—a side effect—associated with a prescribed medication.
But many people with mental illness don’t have the wherewithal to seek help.
Such was the case …
Lawsuit Targets Missouri Over Psychotropic Drug Use Among Foster Care Children
A new lawsuit has been filed in Missouri on behalf of foster care children who were allegedly prescribed Risperdal and other psychotropic drugs inappropriately.
The child advocates behind the lawsuit want the state to implement systemic changes that …
‘Chemical straight-jackets:’ Lawsuit claims Missouri foster kids prescribed too many meds
The five plaintiffs, identified by their initials, include two- and three-year-old sisters who were allegedly prescribed Risperdal, an antipsychotic not approved by the Food and Drug Administration for children under five.
Another plaintiff, aged 12 …
Missouri Sued Over Psychotropic Drugs for Foster Care Kids
JEFFERSON CITY, Mo.
Child advocates filed a federal lawsuit against the Missouri Department of Social Services on Monday over allegations of inappropriately providing psychotropic drugs to foster care children and systemic lack of oversight of …
More details here
Janssen Pharmaceuticals granted nonsuit motion in latest Philadelphia Risperdal lawsuit
The latest Risperdal lawsuit to go to trial here has been dismissed by a state court judge for a piece of photographic evidence allegedly lacking authentication, marking the fifth courtroom victory for the drug’s manufacturer, Janssen …
J&J Faces 3000 More Risperdal Gynecomastia Lawsuits
An additional 3,000 plaintiffs filed Risperdal (risperidone) gynecomastia lawsuits against Johnson & Johnson and Janssen Pharmaceuticals in 2017, bringing the total to more than 5,500, Forbes reported.
According to reports from the Philadelphia Court …
Xarelto manufacturers win jury verdict in first federal bellwether trial on drug’s potential risk liability
The group of more than 18,000 Xarelto lawsuits have been consolidated through the federal court system’s multi-district litigation (MDL) process.
This process utilizes bellwether trials to establish evidence and determine any settlement value for similar …
— Riya Verma (@RiyaSuper) May 6, 2017
First Xarelto Bellwether Trial Ends In Defense Verdict
According to Fierce Pharma, Joseph Boudreaux was the first patient to file a Xarelto lawsuit in the United States.
His claim is now joined by around 18,000 other lawsuits, many of which have been consolidated in the US District Court for the Eastern …
— Alex Jones (@RealAlexJones) April 27, 2017
First Xarelto federal bellwether trial beginning in Louisiana
The initial bellwether trial to ascertain whether the manufacturers of Xarelto are liable for claims which allege the blood-thinning medication caused injury or death to more than 15,000 patients was slated to begin Monday in Louisiana …
Fresenius slips 1st Naturalyte bellwether trial
Fresenius Medical Care (NYSE:FMS) last week won the 1st bellwether trial in a series of product liability lawsuits brought over its GranuFlo and NaturaLyte dialysis drugs, after a Massachusetts jury found that the plaintiff’s estate failed to prove its …
Beshear sues nation’s largest kidney dialysis provider
Beshear claimed in the suit filed in Franklin Circuit Court that Fresenius, headquartered in Waltham, Mass., promoted its kidney dialysis product, GranuFlo, as safe despite clinical trials finding it harmful.
The lawsuit seeks to recover damages and …
Lawsuit claims DaVita hid harmful effects of dialysis solution that caused heart attacks
The lawsuit says that since at least 2004, DaVita used a dialysis solution called GranuFlo that caused complications including heart attacks and strokes.
On Nov. 4, 2011, an internal study by Fresenius Medical Care, the maker of GranuFlo, resulted in a …
$250 Million Settlement Reached in Granuflo Litigation
Fresenius Medical Care, one of the largest providers of dialysis products in the world, has agreed to set aside $250 million to settle more than 10,000 lawsuits filed by dialysis patients and family members.
The plaintiffs in those lawsuits allege use …
Fresenius pays $250M to settle GranuFlo/NaturaLyte lawsuits
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) agrees to pay $250M to resolve U.S. litigation related to its GranuFlo and NaturaLyte products.
Under the terms of the agreement, 97% of the plaintiffs must agree to the settlement by July to receive …
First Xarelto federal bellwether trial beginning in Louisiana
Philadelphia’s Complex Litigation Center is also expected to see its first trial this year.
Plaintiffs charge Xarelto manufacturers with failing to properly warn patients that Xarelto use presented increased risks for cranial and gastrointestinal …
— Max Mitchell (@MMitchellTLI) April 26, 2017
J&J, Bayer Accused of Hiding Xarelto Dangers in First Trial
Joseph Boudreaux took Xarelto to help cut his stroke risk, but instead the drug caused serious gastrointestinal bleeding, according to his lawsuit.
Boudreaux spent a week in the intensive care unit and needed several blood transfusions and heart …
J&J, Bayer Accused of Hiding Blood-Thinning Drug’s Flaws
Joseph Boudreaux says taking Johnson & Johnson’s blood-thinning drug Xarelto was one of the biggest mistakes of his life.
While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding that required a week …
First Xarelto Case to Test Views Over Attorney Ads
House Judiciary Committee Chairman Bob Goodlatte, who co-authored a tort reform bill that the U.S. House of Representatives passed last month, referenced the Xarelto litigation in letters last month calling on the American Bar Association and various …
Pharmaceutical companies seeking to ascertain if third-party funding in Xarelto litigation
In their motion, Xarelto manufacturers asked if any third-party “has the right to control or be consulted about the plaintiffs’ litigation and whether there is a third-party source of funding for the plaintiffs’ litigation”, in addition to seeking the …
Xarelto Makers Want Plaintiffs' Litigation Funding Info https://t.co/bhaJvAIx0v
— Mass Tort Journal (@MassTortJournal) April 18, 2017
Defendants on Philadelphia Xarelto Mass Tort Seek Disclosure of Third-Party Funding
As the Philadelphia Xarelto mass tort moves closer towards the bellwether trial stage, Xarelto principles Bayer AG and Janssen Pharmaceuticals have signaled that they want to know the identity of any third-party funders associated with …